Akero Therapeutics Inc (AKRO) — Financial Flexibility Index
Akero Therapeutics Inc (AKRO) has a Financial Flexibility Index of -1.40x as of September 2025. Free cash flow of $-67.17 Million (operating CF $-67.17 Million minus capex $0.00) represents -1% of total liabilities ($47.94 Million). Also explore Akero Therapeutics Inc equity growth rate to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Akero Therapeutics Inc Financial Flexibility Index (2017–2024)
Historical Financial Flexibility Index trend for Akero Therapeutics Inc across 8 annual periods. Check Akero Therapeutics Inc PP&E and investment ratio to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Akero Therapeutics Inc (2017–2024)
Year-by-year free cash flow to debt coverage for Akero Therapeutics Inc. For the full company profile including market capitalisation, see market cap of Akero Therapeutics Inc.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -3.02x | $-229.11 Million | $-230.11 Million | $75.77 Million | ▲ +6.5% |
| 2023 | -3.23x | $-145.37 Million | $-145.37 Million | $44.97 Million | ▼ -4.9% |
| 2022 | -3.08x | $-92.52 Million | $-92.52 Million | $30.01 Million | ▼ -2.3% |
| 2021 | -3.01x | $-79.68 Million | $-79.68 Million | $26.44 Million | ▲ +37.6% |
| 2020 | -4.83x | $-70.66 Million | $-70.80 Million | $14.63 Million | ▼ -27.9% |
| 2019 | -3.78x | $-35.48 Million | $-35.63 Million | $9.39 Million | ▼ -128104.4% |
| 2018 | 0.00x | $375.00K | $-4.62 Million | $127.07 Million | ▲ +100.4% |
| 2017 | -0.81x | $-4.23 Million | $-4.38 Million | $5.22 Million | — |